Key result
Familial high Lp(a) is linked to ~28% higher MACE risk in first-degree relatives.
Why the study?
Does being a first-degree relative of an individual with elevated Lp(a) increase the risk of major adverse cardiovascular events?
Cohort (n=61,715)
Does being a first-degree relative of an individual with elevated Lp(a) increase the risk of major adverse cardiovascular events?
Hazard Ratio: 1.28 (95% CI 1.06–1.55)
Absolute Event Rate: 8.1% vs 6.2%
p-value: p=<0.001
First-degree relatives of individuals with elevated Lp(a) levels have a significantly higher incidence of major adverse cardiovascular events, supporting the potential utility of cascade screening.
Lipoprotein(a) [Lp(a)] levels are genetically determined and causal in the development of atherosclerotic cardiovascular disease. Whether first-degree relatives (FDR) of individuals with elevated Lp(a) levels (≥80th percentile) have an increased cardiovascular disease risk is unknown. Based on 41,304 indexes with a routine plasma Lp(a) measurement, 61,715 FDR without a measured Lp(a) aged 35-69 years (49% women) were identified in the Swedish STRIREG cohort. FDR were stratified according to index Lp(a) percentile level: <50th, 50-<80th, 80-<95th and ≥95th. In competing risk-adjusted cumulative incidence and adjusted Cox proportional hazards regressions, the association between Lp(a) strata and major adverse cardiovascular events (MACE; cardiovascular death, myocardial infarction, ischaemic stroke, coronary revascularization) was investigated. In a nested analysis of 4243 indexes with a first-degree relationship with another index, the concordance of plasma Lp(a) levels was assessed. During a median follow-up of 19 (11-26) years, 2043 FDR had a MACE. The cumulative incidences of MACE in FDR until age of 65 were 6.2%, 7.0%, 7.5%, and 8.1% by increasing index Lp(a) level strata (P<0.001). Compared with FDR in the lowest Lp(a) stratum, there was a higher hazard ratio for MACE by increasing Lp(a) stratum: 1.08 (95% confidence interval, 0.97-1.19), 1.30 (1.15-1.47), and 1.28 (1.06-1.55; Ptrend<0.001). The Lp(a) concordance was 86% (<80th percentile) and 53% (≥80th percentile). FDR of individuals with elevated Lp(a) levels have a higher incidence of MACE. Cascade screening could be a feasible strategy to identify FDR at heightened risk.
No takes yet. Share an insight, caveat, or question.
Kindborg et al. (2025) conducted a cohort in Elevated plasma lipoprotein(a) (n=61,715). Elevated index Lp(a) level (≥95th percentile) vs. Lowest index Lp(a) stratum (<50th percentile) was evaluated on Major adverse cardiovascular events (MACE; cardiovascular death, myocardial infarction, ischaemic stroke, coronary revascularization) (HR 1.28, 95% CI 1.06-1.55, p=<0.001). First-degree relatives of individuals with the highest Lp(a) levels (≥95th percentile) had a higher risk of MACE compared to those in the lowest stratum (HR 1.28; 95% CI 1.06-1.55; Ptrend<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: